Dose Titration
Gradually increasing a peptide dose from a low starting point — standard practice for GLP-1s, GHRH analogs and any protocol with GI or tolerance profiles.
Definition
Titration is the staged escalation of a drug from a below-therapeutic starting dose to the target dose, typically in two- or four-week increments. The purpose is to let the body acclimate — for GLP-1 receptor agonists, titration reduces nausea; for GHRH analogs, it avoids over-shooting IGF-1. Protocol cards at Meto always specify the titration cadence.
Read More
GLP-1 Receptor AgonistGLP-1 RA
A peptide drug class that mimics glucagon-like peptide-1 to slow gastric emptying, sharpen insulin response and quiet food-noise.
BiomarkerIGF-1Insulin-like Growth Factor 1
The primary blood marker of growth-hormone activity — the lab that gates any GH-axis protocol and the one re-checked at month 3.
Delivery & DosingSubcutaneous InjectionSQ Injection
Injection into the fatty layer just below the skin — the standard route for peptide dosing, self-administered with an insulin syringe.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.